NextCure

-$0.21 (-3.38%) Today
$0.00 (0.00%) As of 10:37 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NextCure and other ETFs, options, and stocks.

About NXTC

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines.

CEO
Michael S. Richman
Employees
90
Headquarters
Beltsville, Maryland
Founded
2015

NXTC Key Statistics

Market cap
165.67M
Price-Earnings ratio
—
Dividend yield
—
Average volume
289.35K
High today
$6.23
Low today
$5.95
Open price
$6.23
Volume
150.70K
52 Week high
$14.40
52 Week low
$5.59

NXTC Earnings

-$0.67
-$0.34
-$0.00
$0.33
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure